Michigan State
FDA Grants Emergency Use Authorization for Michigan State University COVID-19 Molecular Assay
The laboratory-developed test uses nasopharyngeal swab samples and RT-LAMP for the qualitative detection of SARS-CoV-2 virus in symptomatic patients.
Researchers combined a new and established biomarker to detect nearly 70 percent of pancreatic cancers with a less than 5 percent false-positive rate.